# US 2014/0348961 A1 · Sirtuin activator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0348961 A1
- Document ID: US20140348961A1
- Status: Published application
- Kind: A1
- Application number: 14/368,457
- Filed: 2012-12-27
- Published: 2014-11-27
- Earliest claimed: 2011-12-27
- Assignees: Masaki ABURADA; Tokiwa Phytochemical Co., Ltd.
- Applicants: Tokiwa Phytochemical Co., Ltd.
- Inventors: Tsutomu Shimada; Jinwei Yang; Yuka Koike
- Web page: https://patentgrep.com/patent/US20140348961A1

## CPC

- C07D 311/32: 2,3-Dihydro derivatives, e.g. flavanones
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 8/9794: Liliopsida [monocotyledons]
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 36/9068: Zingiber, e.g. garden ginger
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/50: for increasing or potentiating the activity of insulin
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 19/00: Preparations for care of the skin
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K 2800/10: General cosmetic use
- A61K 2800/78: Enzyme modulators, e.g. Enzyme agonists
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention provides a sirtuin activator with an active component composed of black ginger or a black ginger extract, which is easily obtainable, extremely safe, and eaten from old. The present invention further provides a sirtuin activator with an active component of polyalkoxyflavonoid compound represented by general formula (I) and having a sirtuin activation effect that is 10 folds that of resveratrol or higher: wherein, R1 to R7 are each independently a hydrogen atom, a hydroxyl group, or a C1 to C6 lower alkoxy group.

## Claims

### Claim 1

A sirtuin activator comprising an active component composed of black ginger or a black ginger extract.

### Claim 2 (depends on 1)

The sirtuin activator according to claim 1, wherein black ginger is a plant having a nomenclature of Kaempferia parviflora.

### Claim 3 (depends on 1, 2)

The sirtuin activator according to either claim 1 or 2 comprising an active component composed of an extract from black ginger obtained by a solvent.

### Claim 4 (depends on 3)

The sirtuin activator according to claim 3, wherein the solvent is selected from water, methanol, ethanol, propanol, isopropanol, butanol, isobutanol, ethyl acetate, or a combination thereof.

### Claim 5 (depends on 4)

The sirtuin activator according to claim 4, wherein the solvent is ethanol.

### Claim 6 (depends on 5)

The sirtuin activator according to claim 5, wherein ethanol is a water-containing ethanol having an ethanol content of 30% to 95% (v/v).

### Claim 7 (depends on 1)

A metabolic syndrome preventative agent comprising the sirtuin activator according to claim 1.

### Claim 8 (depends on 1)

An insulin resistance improving agent comprising the sirtuin activator according to claim 1.

### Claim 9 (depends on 1)

An anti-aging agent comprising the sirtuin activator according to claim 1.

### Claim 10 (depends on 1)

A life-lengthening agent comprising the sirtuin activator according to claim 1.

### Claim 11 (depends on 1)

A food and drink, cosmetics, or a pharmaceutical composition comprising the sirtuin activator according to claim 1.

### Claim 12

A sirtuin activator comprising a polyalkoxyflavonoid compound represented by general formula (I) as an active component:
wherein, R1 to R7 are each independently a hydrogen atom, a hydroxyl group, or a C1 to C6 lower alkoxy group.

### Claim 13 (depends on 12)

The sirtuin activator according to claim 12, wherein the polyalkoxyflavonoid compound is a polymethoxyflavonoid compound represented by general formula (II):
wherein R11, R12, R14, R15 and R16 are each independently a hydrogen atom, a hydroxyl group, or methoxy, and R13 is a hydrogen atom or a methyl group.

### Claim 14 (depends on 12, 13)

The sirtuin activator according to claim 12 or 13, wherein the compound of general formula (I) or (II) is selected from a group consisting of apigenin-5,7,4′-trimethylether, quercetin-3,5,7,3′,4′-pentamethylether, chrysin dimethylether, 3,5,7,4′-tetramethoxyflavone, and 3,5,7-trimethoxyflavone.

### Claim 15 (depends on 12)

A metabolic syndrome preventative agent, an anti-aging agent, a life-lengthening agent, a cancer preventative agent, a cardiovascular disease preventative agent, or an anti-inflammatory agent comprising the sirtuin activator according to claim 12.

### Claim 16 (depends on 12)

An insulin resistance improving agent comprising the sirtuin activator according to claim 12.

### Claim 17 (depends on 12)

A life-lengthening agent comprising the sirtuin activator according to claim 12.

### Claim 18 (depends on 12)

A food and drink, cosmetics, or a pharmaceutical composition comprising the sirtuin activator according to claim 12.
